Mainiero, M. B. et al. ACR appropriateness criteria breast cancer screening.
According to the inclusion criteria, breast cancer tissue specimens from 77 patients were eligible for analysis.
Inclusion criteria: Breast cancer tissue samples of patients that had up to 60 months follow-up and availability of clinical, pathological and treatment data in the clinical database.
Based on these criteria, breast cancers were graded into grade I (score ≤ 5), grade II (score 5 9), and grade III (score ≥ 10).
Exclusion criteria: Breast cancer tissues were not considered for this study if patients follow up data were not available in the clinical database.
A total of 29 studies satisfied the inclusion criteria (breast 14, colorectal 2, prostate 10, cervical 0, head and neck 3).
Four cancers met these criteria, breast invasive cancer (BrCa), Glioblastoma multiforme (GBM), kidney renal clear cell carcinoma (KIRC), and ovarian serous cystadenocarcinoma (OvCa).
They were diagnosed by the lactation consultants attending different primary health-care centers in Spain and met the following criteria: breast redness and pain, flu-like symptoms (including fever ≥ 38.5°C) and a leukocyte count higher than 6 log10 cfu mL-1.
Among them, a total of 289 African American patients were included in the present study based on meeting at least one of the following criteria: breast cancer diagnosis before age 45; personal history of both breast and ovarian cancer; TNBC; or family history of breast cancer before age 60 or of ovarian cancer at any age in a first or second degree relative.
All mammograms complied with the following minimum quality criteria: breast situated centrally with the nipple in profile, visualization of all the breast tissue, the pectoral muscle shadow reached the nipple level, the nipple was seen in profile, and the inframamammary angle could be visualized.
